Reaction
Conjunctival Oedema reporting signals
As of the last recalculation, Conjunctival Oedema appears in 1,015 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 51.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bupivacaine | 23 | 51.6 | 51.8 |
| Cefuroxime | 21 | 38.4 | 38.5 |
| Tobramycin Solution | 14 | 24.2 | 24.2 |
| Tobramycin Sulfate | 14 | 23.5 | 23.5 |
| Prednisolone Acetate | 10 | 20.0 | 20.0 |
| Moxifloxacin Hydrochloride | 18 | 18.5 | 18.5 |
| Timolol Maleate | 8 | 16.7 | 16.7 |
| Cefazolin | 7 | 15.8 | 15.8 |
| Tobramycin | 18 | 15.6 | 15.6 |
| Brimonidine Tartrate | 13 | 15.1 | 15.2 |
| Iohexol | 6 | 14.9 | 14.9 |
| Lifitegrast | 11 | 13.9 | 14.0 |
| Nevirapine | 6 | 13.7 | 13.7 |
| Cefazolin Sodium | 8 | 13.7 | 13.7 |
| Zoledronic Acid | 25 | 13.1 | 13.1 |
| Rocuronium Bromide | 7 | 12.3 | 12.3 |
| Brinzolamide | 5 | 11.9 | 11.9 |
| Faricimab | 4 | 10.2 | 10.2 |
| Ranibizumab | 11 | 8.6 | 8.6 |
| Oseltamivir | 3 | 7.7 | 7.7 |
| Aflibercept | 11 | 7.3 | 7.3 |
| Cenegermin-Bkbj | 4 | 6.8 | 6.8 |